Orhun H Kantarci, MD

  • 3267 Citations
  • 30 Scopus h-Index
19972019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1997 2019

Filter
Chapter
2017
1 Citation (Scopus)

Timing of future remyelination therapies and their potential to stop multiple sclerosis progression

Zeydan, B., Rodriguez, M. & Kantarci, O. H., Jan 1 2017, Advances in Experimental Medicine and Biology. Springer New York LLC, Vol. 958. p. 161-170 10 p. (Advances in Experimental Medicine and Biology; vol. 958).

Research output: Chapter in Book/Report/Conference proceedingChapter

Multiple Sclerosis
Recurrence
Therapeutics
Recovery
Oligodendroglia
2015

Biomarkers for phase switches in multiple sclerosis

Turanli, E. T., Avsar, T., Uygunoğlu, U., Kantarci, O. H. & Siva, A., Sep 2 2015, General Methods in Biomarker Research and their Applications. Springer International Publishing, Vol. 2-2. p. 1053-1080 28 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Multiple Sclerosis
Biomarkers
Demyelinating Diseases
Relapsing-Remitting Multiple Sclerosis
Early Diagnosis
2006

Multiple sclerosis

Kantarci, O. H. & Weinshenker, B. G., Jan 1 2006, Cytokine Gene Polymorphisms in Multifactorial Conditions. CRC Press, p. 289-304 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Multiple Sclerosis
Recurrence
Chronic Progressive Multiple Sclerosis
Neurology
Demyelinating Diseases
2001
8 Citations (Scopus)

Prognostic factors in multiple sclerosis

Kantarci, O. H. & Weinshenker, B. G., Jan 1 2001, Handbook of Multiple Sclerosis, Third Edition. CRC Press, p. 449-463 15 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Multiple Sclerosis
Therapeutics
Physicians
Patient Rights
Interferons